Cited by 11Chronic Lymphocytic Leukemia ResearchLymphoma Diagnosis and TreatmentHematological disorders and diagnostics

Diagnosis, biology and treatment of hairy-cell leukaemia

Allsup, D. J., Cawley, J. C.·2004·Clinical and Experimental Medicine

Abstract

Hairy-cell leukaemia (HCL) is usually readily diagnosed by seeing typical hairy cells (HCs) in the blood film. The diagnosis is then confirmed by tartrate-resistant acid phosphatase staining, marker analysis, and bone marrow examination. HCs are clonal mature memory B cells with specific features of activation. This HC activation is responsible for many of the pathological features of the disease, including its distinctive bone marrow fibrosis, splenic red pulp invasion, and pseudo-sinus formation. Chlorodeoxyadenasine is the treatment of first choice. Deoxycoformycin and rituximab are useful for the treatment of relapsed/refractory disease. The nature of the primary oncogenic event(s) remains unknown and is the major unresolved issue in HCL.

Integrity signals

Registry

Crossref · 10.1007/s10238-004-0046-z

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • RhoH expression levels are a crucial factor in protection from the development of haematopoietic malignancies.

    “Nevertheless, the recent finding that RHOH is underexpressed in certain types of leukaemia implies that RhoH expression levels are a crucial factor in protection from the development of haematopoietic malignancies [56,57].”
  • Most data gathered so far indicate that in human cancers the absence of a functional RhoH protein or reduced RhoH expression levels rather than its overexpression may play a role in pathogenesis.

    “Most data gathered so far however indicate that in human cancers the absence of a functional RhoH protein or reduced RhoH expression levels rather than its overexpression may play a role in pathogenesis [32,56,57].”
  • RHOH is underexpressed in certain types of leukaemia.

    “Nevertheless, the recent finding that RHOH is underexpressed in certain types of leukaemia implies that RhoH expression levels are a crucial factor in protection from the development of haematopoietic malignancies [56,57].”

Cited by

Sorted by citations

Authors
Allsup, D. J., & Cawley, J. C.
Affiliations
  • Hull Royal Infirmary (GB)
  • Royal Liverpool University Hospital (GB)
Corresponding author
Allsup, D. J.
Venue
Clinical and Experimental Medicine
Published
2004-12
Volume
4
Issue
3
Pages
132-138
ISSN
  • 1591-8890 (ISSN-L)
  • 1591-9528
OpenAlex
W2007590926
Cited by
11
References
0
Citations by year
2014: 1 · 2012: 1
FWCI
0.92
Type
journal article
Language
en
Open access
closed
Locations
  • Clinical and Experimental Medicine (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Genetics › Chronic Lymphocytic Leukemia Research
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Lymphoma Diagnosis and Treatment
  • Health Sciences › Medicine › Emergency Medicine › Hematological disorders and diagnostics
Keywords
hairy cell leukemia, hairy cells, B cell activation, bone marrow fibrosis, deoxycoformycin, rituximab, relapsed/refractory disease, pathogenesis
MeSH terms
Diagnosis, Differential, Humans, Leukemia, Hairy Cell

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review